Impact of coronavirus disease 2019 on diabetic patients: An endocrinological perspective for better management

Himanshu Agrawal; Neeladrisingha Das; Sandip Nathani; Partha Roy

doi:10.25259/JRHM_29_2020

View/Download PDF

Review Article

2 (

Suppl_1

); 85-91

doi:

10.25259/JRHM_29_2020

Buy Reprints

PDF

Impact of coronavirus disease 2019 on diabetic patients: An endocrinological perspective for better management

Himanshu Agrawal¹, Neeladrisingha Das¹, Sandip Nathani¹, Partha Roy¹

1Department of Biotechnology, Indian Institute of Technology, Roorkee, Uttrakhand, India

*Corresponding author: Himanshu Agrawal, Department of Biotechnology, Indian Institute of Technology, Roorkee, Uttrakhand, India. himanshu3617@gmail.com

Received: 2020-10-30, Accepted: 2021-01-30, Published: 2021-02-22

Licence

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Agrawal H, Das N, Nathani S, Roy P. Impact of Coronavirus disease 2019 on diabetic patients: An endocrinological perspective for better management. J Reprod Healthc Med 2021;2(Suppl_1):S85-S91.

Abstract

The current pandemic of coronavirus disease 2019 (COVID-19) has led to severe health-related distress globally. Worldwide, different vaccines have been proven safe and effective against COVID-19. However, at present, immunization is permitted for the individuals involved in health sector in India and therefore still requires special care. Elderly people especially with other chronic ailments are the most vulnerable population for this infection. Diabetes is one such ailment which makes an individual more vulnerable toward this viral infection and if infected, the chances of survival of such individuals are very low. In the current review, we have discussed the endocrine aspects which might be responsible for the high mortality rate due to COVID-19 in diabetic patients.